Drug Delivery Letters
PLGA-Based Polymeric Nanoparticles for Voglibose Delivery in Antidiabetic Therapy
Introduction: Diabetes mellitus is a chronic metabolic disorder requiring innovative therapeutic approaches. Voglibose, an effective α-glucosidase inhibitor, has limitations, including low solubility and a short duration of action when taken as a tablet. Polymeric nanoparticles, particularly PLGA (Poly-lactic-co-glycolic acid), offer promising platforms for sustained drug release and improved bioavailability. This study aimed to develop and evaluate PLGA-based nanoparticles for delivering voglibose, enhancing its t …